Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Botulinum toxin type A for chronic post-surgical neuropathic pain
IRCT20141023019640N5Phase 3Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Sep 2024
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of botulinum toxin type A in Neuralgia, sponsored by Tehran University of Medical Sciences. Started Sep 2024; status: completed.
02
Drugs
botulinum toxin type A
03
Conditions
Neuralgia
Beyond the preview
Go deeper on IRCT20141023019640N5.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20141023019640N5.